分割または減算:トランスフェリン飽和度と無結合鉄結合能力 (UIBC)
Arne Åsberg1, Ann Elisabeth Åsberg2, Øyvind Skadberg1
1Department of Medical Biochemistry, Stavanger University Hospital, Stavanger, Norway.
Scandinavian journal of clinical and laboratory investigation
|February 20, 2026
まとめ
無結合鉄結合能力 (UIBC) は,トランスファーリン飽和度 (TSAT) と比較して,鉄欠乏症の診断に優れた精度を提供します. UIBCは炎症の影響も少なく,より信頼性の高い指標となります.
科学分野:
- 臨床化学 臨床化学について
- 血液学 ヘマトロジ
- 診断医学 診断医学
背景:
- 血トランスリン飽和度 (TSAT) は,鉄欠乏症の伝統的なマーカーですが,炎症の影響を受けます.
- 血フェリチンは鉄欠乏症の好ましい指標ですが,TSATは依然として広く使用されています.
- 炎症中の無結合鉄結合能力 (UIBC) の行動は十分に理解されていません.
研究 の 目的:
- 鉄欠乏症に対するUIBCとTSATの診断精度を評価する.
- 炎症がUIBC,TSAT,フェリチンレベルに与える影響を評価する.
- 大規模な患者集団における鉄欠乏の指標としてUIBCとTSATを比較する.
主な方法:
- 21681人の患者のデータを横断分析した.
- UIBC,TSAT,フェリチン,およびC反応性タンパク質 (CRP) の関係に関する調査.
- 非炎症性サブ集団 (CRP ≤ 1 mg/L) の基準基準としてフェリチン値 (15, 20, 30 μg/L) を使ったROC曲線を用いた診断精度の比較.
主要な成果:
- UIBCでは,TSATとフェリチンと比較して,CRPレベルでの変動が著しく少ないことが示されました.
- UIBCは,TSATと比較して,鉄欠乏症の診断の精度が優れていた (AUC 0.894対0.850,フェリチン<20μg/Lを使用した).
- 60μmol/LのUIBC値は,鉄欠乏症を示すフェリチンレベル20μg/Lと一致しました.
結論:
- UIBCの計算は,TSATよりも鉄欠乏のより正確な評価を提供します.
- UIBCは,特に炎症がある場合に,鉄欠乏症のより強力な診断マーカーです.
- UIBCは,鉄欠乏症の診断のために,血鉄と鉄結合能力の測定を活用するための優れた方法を表しています.
関連する概念動画
The Early Endosome: Endocytosis of Transferrin
4.9K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.9K
Drug Distribution: Plasma Protein Binding
9.9K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
9.9K
Oxygen Transport in the Blood
7.3K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
7.3K
Physiological Pharmacokinetic Models: Assumption with Protein Binding
282
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
282
Hepatic Drug Clearance: Effect of Protein Binding
596
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
596
Blood Transfusion and Agglutination
15.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.1K


